HY-10581-1g
|
MedChemexpress LLC
|
Gatifloxacin [CAS 112811-59-3]
|
|
COVID-19-anti-virus
|
|
HY-10581-5g
|
MedChemexpress LLC
|
Gatifloxacin [CAS 112811-59-3]
|
|
COVID-19-anti-virus
|
|
HY-10581-500mg
|
MedChemexpress LLC
|
Gatifloxacin [CAS 112811-59-3]
|
|
COVID-19-anti-virus
|
|
HY-10581A-1g
|
MedChemexpress LLC
|
Gatifloxacin (hydrochloride) [CAS 121577-32-0]
|
|
COVID-19-anti-virus
|
|
HY-10581A-5g
|
MedChemexpress LLC
|
Gatifloxacin (hydrochloride) [CAS 121577-32-0]
|
|
COVID-19-anti-virus
|
|
HY-10581A-500mg
|
MedChemexpress LLC
|
Gatifloxacin (hydrochloride) [CAS 121577-32-0]
|
|
COVID-19-anti-virus
|
|
HY-109785A-1mg
|
MedChemexpress LLC
|
(R)-Gyramide A (hydrochloride) [CAS 1793050-70-0]
|
|
|
|
HY-110354-10mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
HY-110354-100mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
HY-110354-25mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
HY-110354-5mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
HY-110354-50mg
|
MedChemexpress LLC
|
UCM05 [CAS 1094451-90-7]
|
|
COVID-19-immunoregulation
|
|
HY-116788-10mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
HY-116788-100mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
HY-116788-25mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
HY-116788-5mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
HY-116788-50mg
|
MedChemexpress LLC
|
Lipofermata [CAS 297180-15-5]
|
|
Cancer-programmed cell death
|
|
HY-124679-10mg
|
MedChemexpress LLC
|
DS86760016 [CAS 1853176-89-2]
|
|
COVID-19-immunoregulation
|
|
HY-124679-100mg
|
MedChemexpress LLC
|
DS86760016 [CAS 1853176-89-2]
|
|
COVID-19-immunoregulation
|
|
HY-124679-25mg
|
MedChemexpress LLC
|
DS86760016 [CAS 1853176-89-2]
|
|
COVID-19-immunoregulation
|
|
HY-124679-5mg
|
MedChemexpress LLC
|
DS86760016 [CAS 1853176-89-2]
|
|
COVID-19-immunoregulation
|
|
HY-124679-50mg
|
MedChemexpress LLC
|
DS86760016 [CAS 1853176-89-2]
|
|
COVID-19-immunoregulation
|
|
HY-125176-10mg
|
MedChemexpress LLC
|
G907 [CAS 2244035-16-1]
|
|
COVID-19-immunoregulation
|
|
HY-125176-100mg
|
MedChemexpress LLC
|
G907 [CAS 2244035-16-1]
|
|
COVID-19-immunoregulation
|
|
HY-125176-5mg
|
MedChemexpress LLC
|
G907 [CAS 2244035-16-1]
|
|
COVID-19-immunoregulation
|
|